Family history and pancreatic cancer risk — what it actually means for you

People who search family history pancreatic cancer are rarely asking an abstract question. They have sat through a parent's, a sibling's or an uncle's diagnosis, and they want to know what it means for themselves and for their children. The honest starting point is that most pancreatic cancer is not inherited. Most people diagnosed have no affected relative at all, and most people with one affected relative never develop it.

What a family history does is shift a threshold rather than deliver a verdict. It changes how seriously a persistent new symptom is taken, whether genetic counselling is offered, and — for a small, well-defined minority — whether a structured surveillance programme is worth discussing. It does not tell you what will happen to you. Nobody can read that from a family tree, and anybody who claims otherwise is selling something.

It helps to separate two things that get muddled together in the same conversation. The first is an inherited gene change — a fault in a gene such as BRCA, PALB2, ATM, CDKN2A or one of the Lynch-syndrome genes, passed down a family line and detectable on a blood test. Which genes are involved, and what each one means, is set out on is pancreatic cancer hereditary? The second is familial clustering — families with several affected blood relatives in whom no gene change is ever found, but whose risk is still treated as raised. That pattern has its own definition and its own consequences, explained on familial pancreatic cancer.

This page sits one step before both of those. It is about reading your own family tree honestly — which relatives count, what the pattern has to look like before it changes anything, and what to do with the answer. For the disease itself, its symptoms and its treatment, start from our complete guide to pancreatic cancer.

• List every blood relative who has had any cancer, not only pancreatic. Breast, ovarian, bowel, prostate and melanoma diagnoses in the same line are part of the picture, and people routinely leave them out.
• Record which side of the family each person is on. Your mother's side and your father's side are read separately, and a list without sides cannot be interpreted.
• Note roughly how old each relative was at diagnosis. An approximation is genuinely useful. “In her forties” is worth far more than a blank.
• Check which organ was actually involved. Pancreatic cancer is often remembered in a family as liver, stomach or gallbladder cancer, because of the jaundice and where the pain was felt. An old hospital letter or discharge summary settles it.
• Ask whether anyone has already had genetic testing, and whether a copy of the report still exists. If it does, bring it — it is the most informative document in this entire conversation.
• Include relatives who died of something else. Someone who died young of an unrelated cause never had the chance to develop a later cancer, and that gap changes how a sparse family tree is read.
• Bring the list, not a conclusion. Working out what the pattern means is our job. Gathering the facts accurately is the part only you can do.

1. 1

   A free 45-minute consultation, not a five-minute triage

   The first appointment is a conversation. We draw the family tree out properly, both sides separately, going back as far as you can reliably remember — because a pattern only becomes visible once it is on paper.

   In-house at CION
2. 2

   The pattern is classified honestly

   Most family trees turn out to be reassuring, and you will be told so directly rather than left with a vague “keep an eye on it.” Where the pattern does meet a recognised definition, we say which one, and what follows from it.

   In-house at CION
3. 3

   Genetic counselling, where the pattern warrants it

   Counselling comes before any test, so you understand in advance what a result would and would not mean — for you, and for the relatives who would have to be told. Where testing is agreed, it is arranged through that service.

   In-house at CION
4. 4

   Imaging only where the criteria are genuinely met

   Pancreatic-protocol CT, MRI with MRCP, CA 19-9 and routine bloods are ordered and reported by CION. None of them is a screening test for a well person with a worried family, and we will say so rather than order one to make an anxiety go away.

   In-house at CION
5. 5

   Endoscopy and surgery, in the rare event they are needed

   Endoscopic ultrasound and biopsy, ERCP and stenting, staging laparoscopy, PET-CT and all pancreatic surgery are arranged with specialist HPB, gastroenterology and endoscopy partner centres, and may be billed there. If a diagnosis is ever made, the pathway from that point is set out in pancreatic cancer treatment in Hyderabad.

   Coordinated with specialist partner centres

Many people arrive expecting that an affected relative buys them a yearly scan. For most, it does not, and the reason is worth understanding rather than resenting. There is no population screening programme for pancreatic cancer anywhere, because no available test performs well enough in people without symptoms to do more good than harm. Scanning a large, low-risk group produces a steady stream of small, meaningless findings, each of which then needs chasing — and that chase carries its own anxiety, cost and, occasionally, real risk.

CA 19-9 is the test people ask for most often, and it is the clearest example. It is genuinely useful for following a cancer that has already been diagnosed. It is not a screening test: it rises in ordinary conditions such as inflammation or blockage of the bile ducts, and some people never produce it at all. A normal result would not have earned the reassurance you took from it, and a mildly raised one would have started an investigation you did not need.

Surveillance does exist, and where it is indicated it works, but it is reserved for people in whom the odds justify it — confirmed carriers of an inherited gene change, and members of families meeting the familial pancreatic cancer definition. If that is your family, this is one of the very few situations in pancreatic cancer where genuinely early detection is a realistic goal, and it is the strongest argument there is for taking a family history seriously instead of filing it away.

To be plain about who does what: the consultation, the family-history assessment, genetic counselling, and the ordering and reporting of pancreatic-protocol CT, MRI/MRCP, CA 19-9 and bloods are delivered in-house by CION across our centres, alongside medical and radiation oncology, nutrition and enzyme support, pain and psycho-oncology care. Endoscopic ultrasound and biopsy, ERCP and stenting, staging laparoscopy, PET-CT and every pancreatic operation are coordinated with specialist partner centres and may be billed there. We would rather you knew that before you booked than discovered it afterwards.

A family history is the one piece of medical information that is never only yours. If a gene change is confirmed in you, your brothers, sisters and children each carry a share of the same question, and they can only act on it if somebody tells them. That conversation is often harder than the test itself, and people put it off for months because they do not want to frighten anyone.

A few things make it easier. Wait until you have an actual result rather than sharing a suspicion, because a suspicion travels badly through a family. Tell people what the finding does and does not mean — that it raises risk, that it is not a diagnosis, and that knowing about it is what makes anything useful possible. Say plainly that testing is a choice, and that a relative who does not want to know is entitled not to. Genetic counselling exists partly for this, and our counselling service will help you plan the conversation and give you something written to pass on.

Where children are still young, there is usually no urgency at all: testing for these gene changes is a decision for adulthood, and nothing is lost by waiting until they can weigh it themselves. What matters is that the information survives — written down, kept somewhere findable, and mentioned to the family doctor.

If you are here because a relative is currently in treatment rather than because of your own risk, the pathway they are on is set out in pancreatic cancer treatment in Hyderabad, and the wider picture in our complete pancreatic cancer guide.

Medical disclaimer: This page explains how a family history of pancreatic cancer is assessed, in general terms, and is reviewed by a CION medical oncologist with reference to NCCN guidance on genetic and familial high-risk assessment and to international consensus guidance on surveillance in individuals at inherited risk. It is general information and not a risk calculation for any individual; your own family history should be discussed with a doctor who can see it in full. Family-history assessment, genetic counselling, pancreatic-protocol CT, MRI/MRCP, CA 19-9 and routine bloods, medical and radiation oncology, nutrition and enzyme (PERT) support, pain, psycho-oncology and survivorship care are delivered by CION. Endoscopic ultrasound and biopsy, ERCP and biliary stenting, staging laparoscopy, PET-CT and all pancreatic surgery are coordinated with specialist HPB, gastroenterology and endoscopy partner centres and may be billed there.